ENASIDENIB
UNII 3T1SS4E7AG

Substance Identification & Data

This profile provides standardized clinical and technical data for Enasidenib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3T1SS4E7AG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1446502-11-9 and the RxNorm Concept ID (RxCUI) 1940332. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3T1SS4E7AG

CAS Registry Number

1446502-11-9

RxNorm Concept ID

1940332

Detailed Substance Profile

Preferred Name

ENASIDENIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

3T1SS4E7AG

The specific atomic composition represented as a molecular structure string.

InChIKey

C19H17F6N7O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DYLUUSLLRIQKOE-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C111573

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

89683805

Unique identification number in the NCBI database of chemical substances.

INN ID

10162

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-54

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N(c1ccnc(C(F)(F)F)c1)c2nc(NCC(O)(C)C)nc(-c3cccc(C(F)(F)F)n3)n2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enasidenib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.